Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway.
SIRT1 Deficiency in Microglia Contributes to Cognitive Decline in Aging and Neurodegeneration via Epigenetic Regulation of IL-1β.
CD226 Gly307Ser Association With Neuromyelitis Optica in Southern Han Chinese.
Mobility and cognitive correlates of dual task cost of walking in persons with multiple sclerosis.
Poster abstracts from the third international symposium on gait and balance in multiple sclerosis: selecting the right measures.
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis.
Does natalizumab therapy worsen neuromyelitis optica?
Application of the fuzzy logic concept in the multiple sclerosis functional composite for scoring the progress of multiple sclerosis.
Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors.
Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders.
[Recent prognosis on etiology and pathophysiology of multiple sclerosis].
Longitudinal interferon-β effects in multiple sclerosis: Differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease.
[The activation of the type I interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data.]
Decoding Signaling and Function of the Orphan G Protein-Coupled Receptor GPR17 with a Small-Molecule Agonist.
Enigmatic GPCR Finds a Stimulating Drug.
Extended interval dosing of natalizumab: a two-center, 7-year experience.
Role of metabotropic glutamate receptor 5 signaling and homer in oxygen glucose deprivation-mediated astrocyte apoptosis.
Effects of Ferrofluid and Phytoalexin Spirobrassinin on Thioflavin-T-Based Fluorescence in Cerebrospinal Fluid of the Elderly and Multiple Sclerosis Patients.
A validated regulatory network for Th17 cell specification.
The role of iron in brain ageing and neurodegenerative disorders.
Pulmonary tuberculosis with neuromyelitis optica: an uncommon association of a common disease.
Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis.
Neuregulin1-β Decreases IL-1β-Induced Neutrophil Adhesion to Human Brain Microvascular Endothelial Cells.
The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis.
Pages
« first
‹ previous
…
232
233
234
235
236
237
238
239
240
…
next ›
last »